| Analysis | Samples | Factors | Units |
|---|---|---|---|
| GC POSITIVE ION MODE | LT Enza-IACS-1 | Treatment:30nM IACS-010759 | abundance |
| GC POSITIVE ION MODE | LT Enza-IACS-2 | Treatment:30nM IACS-010759 | abundance |
| GC POSITIVE ION MODE | LT Enza-IACS-3 | Treatment:30nM IACS-010759 | abundance |
| GC POSITIVE ION MODE | Naive-IACS-1 | Treatment:30nM IACS-010759 | abundance |
| GC POSITIVE ION MODE | Naive-IACS-2 | Treatment:30nM IACS-010759 | abundance |
| GC POSITIVE ION MODE | Naive-IACS-3 | Treatment:30nM IACS-010759 | abundance |
| GC POSITIVE ION MODE | LT Enza-NT1 | Treatment:Vehicle (DMSO) | abundance |
| GC POSITIVE ION MODE | LT Enza-NT2 | Treatment:Vehicle (DMSO) | abundance |
| GC POSITIVE ION MODE | LT Enza-NT3 | Treatment:Vehicle (DMSO) | abundance |
| GC POSITIVE ION MODE | Naive-NT1 | Treatment:Vehicle (DMSO) | abundance |
| GC POSITIVE ION MODE | Naive-NT2 | Treatment:Vehicle (DMSO) | abundance |
| GC POSITIVE ION MODE | Naive-NT3 | Treatment:Vehicle (DMSO) | abundance |
Return to study ST002856 main page
Download data matrix(Validation of on-target effect of IACS-010759 in vehicle- and Enzalutamide-treated 16D cells GC POSITIVE ION MODE)
- Metabolomics Workbench
|